Irene Grzybowski

Non Executive Board Member at ExcellGene SA
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Languages
  • English -
  • Polish -
  • Russian -

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

5.0

/5.0
/ Based on 1 ratings
  • (1)
  • (0)
  • (0)
  • (0)
  • (0)

Filter reviews by:

Laurie Harp, CBAP

Irene and I recently partnered together on project initiatives and platform migrations at Fidelity Investments. Professional, detail-oriented, and solution driven are a few descriptive words that come to mind when I consider our time together. Irene is a pleasure to work with and I would jump at the chance to be on her team again.

You need to have a working account to view this content.
You need to have a working account to view this content.

Experience

    • Switzerland
    • Biotechnology Research
    • 1 - 100 Employee
    • Non Executive Board Member
      • Nov 2020 - Present

      ExcellGene is a highly innovative biotechnology company redefining the industry with its proprietary protein expression technologies. ExcellGene is a highly innovative biotechnology company redefining the industry with its proprietary protein expression technologies.

    • United States
    • Financial Services
    • 700 & Above Employee
    • Project Manager, Fidelity Investments
      • Nov 2020 - Present

    • Business Consultant
      • 2017 - Present

      Provide consulting services, including hands-on project implementation, to small and medium-sized businesses focused on business transformation and process optimization, development and implementation of new business and growth strategies, screening of investment proposals and underwriting of complex equity investments. Clients have included: ➢ Boston Capital Corporation, a leading multifamily housing investment company. Led and implemented major change management project collaborating with executive team materially improving underwriting product and processes, removing silos around underwriting and sales. Underwrite investment proposals. ➢ ARGO Global Capital, a private venture capital investor. Developed strategy for healthcare fraud tech start-up. Evaluate investment proposals. ➢ Reliva CBD, a leading retail CBD brand. Evaluated production processes, web sales and new product development capabilities. Made recommendations enabling scaling and realization of growth opportunities.

    • Banking
    • 700 & Above Employee
    • Senior Banker and Managing Director
      • Dec 2011 - Dec 2016

      Mandated to lead strategic sales initiative aimed at acquisition and development of Top Tier domestic and international debt and equity clients. ➢ Created and developed team that consistently outperformed critical sales, revenue growth and profitability targets by 12-22%. ➢ As head of UIC, grew international client penetration and profitability. Redefined strategy and service model brought in suitable talent, transformed team to leadership in international client revenue generation, increasing revenues by 15% in first year alone while achieving profitability and risk targets.

    • President and CEO
      • 2007 - 2011

      Chartered to transform the Group's leasing business and sustainably drive sales revenues, asset quality, efficiency and profitability. ➢ Defined new corporate strategy, introduced new product lines, reviewed and optimized key internal processes, implemented new IT structure, introduced metrics based management and intensive coaching to grow and empower management. ➢ Planned and successfully executed the legal merger and operational integration of three separate leasing companies, resulting in ca. 30% reduction in costs during first full year, with no loss of key talent or clients. ➢ In the first 2 years of full P&L responsibility, materially improved operating performance leading the firm to the #1 industry position in profitability from #7 and to the #2 industry position in sales from #9. Consistently achieved double-digit revenue and profitability growth as well as market recognition for product quality.

    • Banking
    • 700 & Above Employee
    • Executive Board Member and Head of Corporate & International Banking Division
      • 2004 - 2007

      Recruited to reorganize Corporate & Investment Banking Division to achieve and sustain market leadership. ➢ Actively contributed to governance and leadership of Bank Pekao, a publicly listed bank - one of the top central European banks – that was amongst the most profitable subsidiaries of UniCredit Group. Member of Bank’s strategic committees - Risk Management, New Product Development, Asset and Liability Management. ➢ As Corporate Banking Division Head, oversaw strategic development and operational management of business with ca. 8,000 customers, €5.1 billion in loan assets, over €5.7 billion in deposits and €180 million in revenues with ca. 500 employees in 28 locations. ➢ Consistently achieved double-digit growth in sales, outperforming KPIs. Led development of, and launched, Bank’s first internet banking platform ahead of schedule and at a fraction of the cost of competing platforms, rivaling the market leader in terms of clients and sales within one year of launch. Drove horizontal and vertical growth and consistently ranked #1 or #2 in corporate banking in the market. ➢ Co-led merger strategy and execution of corporate, investment banking and treasury divisions of two commercial banks resulting in the largest and most sophisticated commercial banking activity in the country.

    • United Kingdom
    • Banking
    • 700 & Above Employee
    • Country Managing Director
      • 1996 - 2004

      Mandated to restructure the debt and equity portfolio, collaborate with major stakeholders to redefine the country strategy and lead new business development. ➢ Working with local and international investors, successfully restructured ca. €500 million portfolio and generated a new portfolio of debt and equity of ca. €1.9 billion of cumulative commitments, representing an increase of 73% relative to prior comparable 6-year period. ➢ Led business development identifying, generating, and managing structured finance and equity investments in financial services, energy, infrastructure, manufacturing, telecommunications and real estate, concluding several landmark transactions. Responsible for managing risk exposure of portfolio and exit strategies. Led the Polish portfolio and activities to become the 2nd largest and most innovative at the EBRD. ➢ Directed the EBRD equity stake, through non-executive board and advisory roles; restructured major national companies in heavy manufacturing, agribusiness and food products, and retail and consumer industries. ➢ Developed and promoted relationships with key stakeholders including public, private, governmental and NGOs.

    • Vice President
      • 1988 - 1995

      Recruited to management training program. Successfully completed program and mandated to manage team of corporate credit officers. At Recoll Management, led restructuring of $500m+ portfolio of commercial real estate loans. Recruited to management training program. Successfully completed program and mandated to manage team of corporate credit officers. At Recoll Management, led restructuring of $500m+ portfolio of commercial real estate loans.

  • Hachijuni Bank Ltd.
    • NewYork, New York, USA
    • Analyst
      • 1987 - 1988

      Analysis of complex leveraged buy-outs and large commercial real estate transactions. Analysis of complex leveraged buy-outs and large commercial real estate transactions.

Education

  • EHESP - École des Hautes Études en Santé Publique
    Public Health / Health Care Management
    2012 - 2013
  • The George Washington University School of Business
    Master in Business Administration, International Business
    1982 - 1985
  • University of Massachusetts, Amherst
    Bachelor of Arts (B.A.), Russian, Central European, East European and Eurasian Studies
    1978 - 1982

Community

You need to have a working account to view this content. Click here to join now